SGMO, KWR, VAR, ORLY, QDEL, SPRT Expected To Be Up After Next Earnings Releases
October 25, 2016 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Wednesday, October 26th 2016 and determining how the stocks have performed After their last 12 quarterly, 6 quarterly and earnings reports. Sangamo BioSciences Inc. (NASDAQ:SGMO), Quaker Chemical Corporation (NYSE:KWR), Varian Medical Systems Inc. (NYSE:VAR), O'Reilly Automotive Inc. (NASDAQ:ORLY), Quidel Corporation (NASDAQ:QDEL), support.com Inc. (NASDAQ:SPRT) are all expected to be Up After their earnings are released Wednesday. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go Up After earnings are released Wednesday:
Symbol Company # of Reports Quarter Release Time SGMO Sangamo BioSciences Inc. October Earnings Q3 After KWR Quaker Chemical Corporation October Earnings Q3 After VAR Varian Medical Systems Inc. October Earnings Q4 After ORLY O'Reilly Automotive Inc. October Earnings Q3 After QDEL Quidel Corporation October Earnings Q3 After SPRT support.com Inc. October Earnings Q3 AfterThis technology is designed to help the stock trader identify those companies that seem to have a consistent pattern of movement before or after the earnings release date, based on the history of earnings releases for that company. It combines a calendar of expected earnings releases with a history of past earnings releases in a way that lets you see if a pattern exists.
Sangamo BioSciences Inc. (NASDAQ:SGMO) - Sangamo BioSciences, Inc., a clinical stage biopharmaceutical company, focuses on the research, development, and commercialization of engineered DNA-binding proteins for therapeutic genome editing and gene regulation. Its proprietary zinc finger DNA-binding protein (ZFP) technology enables specific genome modification and gene regulation. The ZFPs could also be linked to a cleavage domain of a restriction endonuclease to create zinc finger nucleases (ZFNs), proteins that could be used to specifically modify DNA sequences by adding or knocking out specific genes; and ZFP transcription factors (ZFP TFs), proteins that could be used to turn genes on or off. Its lead ZFP Therapeutic candidate includes SB-728-T, a ZFN-mediated autologous cell product for the treatment of human immunodeficiency virus and acquired immunodeficiency syndrome (HIV/AIDS), which is in Phase II and Phase I/II clinical trials. The company also engages in Phase I/II studies of in vivo genome editing applications of ZFP Therapeutics for hemophilia B and MPS I, a lysosomal storage disorder (LSD); and proprietary preclinical programs in hemophilia A and other LSDs. It has collaborative partnerships with Biogen Inc. (Biogen) to research, develop, and commercialize the preclinical ZFP Therapeutic development program in hemoglobinopathies, including sickle cell disease and beta-thalassemia; and with Shire International GmbH to research, develop, and commercialize the preclinical ZFP Therapeutic development program in Huntington s disease. Sangamo Biosciences, Inc. was founded in 1995 and is headquartered in Richmond, California..
Quaker Chemical Corporation (NYSE:KWR) - Quaker Chemical Corporation develops, produces, and markets various formulated chemical specialty products for various heavy industrial and manufacturing applications worldwide. Its products include rolling lubricants used by manufacturers of steel in the hot and cold rolling of steel, and by manufacturers of aluminum in the hot rolling of aluminum; corrosion preventives to protect metal during manufacture, storage, and shipment; and metal finishing compounds to prepare metal surfaces for special treatments, such as galvanizing and tin plating, as well as to prepare metal for further processing. The company also offers machining and grinding compounds for use in cutting, shaping, and grinding metal parts; forming compounds to facilitate the drawing and extrusion of metal products; bio-lubricants for forestry and construction industries; hydraulic fluids for steel, metalworking, and other customers to operate hydraulic equipment; and chemical milling maskants for the aerospace industry. In addition, it provides temporary and permanent coatings for metal and concrete products; construction products, including flexible sealants and protective coatings for various applications; specialty greases; die casting lubricants; and chemical management services. The company serves various industries, such as steel, aluminum, automotive, mining, aerospace, tube and pipe, cans, and other industries. It markets and sells its products directly, as well as through distributors and agents. The company was formerly known as Quaker Chemical Products Corporation and changed its name to Quaker Chemical Corporation in August 1962. Quaker Chemical Corporation was founded in 1918 and is headquartered in Conshohocken, Pennsylvania..
Varian Medical Systems Inc. (NYSE:VAR) - Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. Its Oncology Systems segment provides hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy. Its products include linear accelerators, brachytherapy afterloaders, treatment simulation, verification equipment, and accessories; and information management, treatment planning, image processing, clinical knowledge exchange, patient care management, decision-making support, and practice management software. This segment serves university research and community hospitals, private and governmental institutions, healthcare agencies, physicians offices, oncology practices, radiotherapy centers, and cancer care clinics. The company s Imaging Components segment provides X-ray imaging components for use in radiographic or fluoroscopic imaging, mammography, special procedures, computed tomography, computer aided diagnostics, and industrial applications. It sells its products to original equipment manufacturers, independent service companies, and end-users. This segment also offers Linatron X-ray accelerators, imaging processing software, and image detection products for security and inspection purposes. In addition, Varian Medical Systems, Inc. provides products and systems for delivering proton therapy; and develops various technologies in the areas of digital X-ray imaging, volumetric and functional imaging, and improved X-ray sources. The company was formerly known as Varian Associates, Inc. and changed its name to Varian Medical Systems, Inc. in April 1999. Varian Medical Systems, Inc. was founded in 1948 and is headquartered in Palo Alto, California..
O'Reilly Automotive Inc. (NASDAQ:ORLY) - O Reilly Automotive, Inc., together with its subsidiaries, engages in the retail of automotive aftermarket parts, tools, supplies, equipment, and accessories in the United States. The company provides new and remanufactured automotive hard parts, such as alternators, starters, fuel pumps, water pumps, brake system components, batteries, belts, hoses, temperature controls, chassis parts, driveline parts, and engine parts; maintenance items comprising oil, antifreeze products, fluids, filters, wiper blades, lighting products, engine additives, and appearance products; and accessories, such as floor mats, seat covers, and truck accessories. Its stores offer auto body paint and related materials, automotive tools, and professional service provider service equipment. The company s stores also offer enhanced services and programs comprising used oil, oil filter, and battery recycling; battery, wiper, and bulb replacement; battery diagnostic testing; electrical and module testing; check engine light code extraction; loaner tool program; drum and rotor resurfacing; custom hydraulic hoses; professional paint shop mixing and related materials; and machine shops. Its stores provide do-it-yourself and professional service provider customers a selection of brand name, house brands, and private label products for domestic and imported automobiles, vans, and trucks. As of December 31, 2015, the company operated 4,571 stores in 44 states. O Reilly Automotive, Inc. was founded in 1957 and is headquartered in Springfield, Missouri..
Quidel Corporation (NASDAQ:QDEL) - Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications primarily in infectious diseases, women s health, and gastrointestinal diseases. The company offers Sofia analyzer, a fluorescent immunoassay system for hospitals, medical centers, and small clinics; various molecular assays, which run on thermocyclers; Sofia influenza A+B and QuickVue influenza tests for the detection of the viral antigens of influenza type A and B; and Sofia strep A fluorescent immunoassay and QuickVue Strep A tests for the detection of group A Streptococcal antigen from throat swabs. It also provides Sofia Respiratory Syncytial Virus (RSV) and QuickVue RSV tests for respiratory syncytial virus; cell culture and DFA detection solutions for the detection of various viral respiratory pathogens; and various traditional cell lines, specimen collection devices, media, and controls for the use in laboratories. In addition, the company offers ELVIS HSV, a cell culture system for the isolation and detection of herpes simplex virus types 1 and 2; and multiplex cell culture solution. Further, it provides Quidel Molecular Direct clostridium difficile assays; Sofia hCG fluorescent immunoassay and QuickVue pregnancy tests, which are used for the detection of hCG in serum or urine for the early detection of pregnancy; Thyretain for the differential diagnosis of Graves disease; and QuickVue Chlamydia test for the detection of Chlamydia trachomatis. Additionally, the company offers QuickVue test, a fecal immunochemical test to detect the presence of blood in stool specimens; indirect fluorescent antibody products; serological tests that measures antibodies circulating in the blood; and diagnostic and research products for oncology, bone health, and autoimmune diseases. Quidel Corporation was founded in 1979 and is headquartered in San Diego, California..
support.com Inc. (NASDAQ:SPRT) - Support.com, Inc. provides cloud-based software and services primarily in North America. It offers Nexus, a cloud based software-as-a-service solution that provides automation and analytics for companies to resolve technology issues and optimize support interactions with their customers. The company also provides technology support services, including computer and mobile device set-up, security and support, virus and malware removal, wireless network set-up, and home security and automation system support services to the consumer, and small and medium business markets. In addition, it offers software products to maintain, optimize, and secure computers and mobile devices, including SUPERAntiSpyware, a software for malware protection and removal; Cosmos for PC, smartphone, and tablet maintenance and optimization; and ARO for PC registry cleaning and repair. The company sells its cloud based services through partners, including communication providers, retailers, and technology companies, as well as markets its end-user software products directly, principally online, and through partners. Support.com, Inc. was founded in 1997 and is headquartered in Redwood City, California..
About BUYINS.NET
BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS Friction Factor - Market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" Naked Shorts (RegSho) - Tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO
INVESTMENTS & TRADING Earnings - Predicts probability, price move and length of move before and after all US stock earnings reports Seasonality - Predicts probability, price move and length of move based on exact time of year for all US stocks Group Correlation - Tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups SqueezeTrigger - Massive database that tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Valuation - Tracks all known valuation models and applies them. GATS - Tracks and quantifies known trading strategies by backtesting, optimizing and running genetic algorithms and neural networks to ascertain best trading strategies. PatternScan - Automates tracking of every technical pattern and predicts next move in stocks. Insider - Tracks insiders trading records and determines trading performance. Trades by higher-level insiders are generally more predictive than trades by lower level insiders Events - Tracks patterns directly correlated to specific events.
SqueezeTrigger is a registered trademark, Reg. No. 3,120,641
DISCLAIMER:
BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.
Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net